Skip to main content
TipRanks
Go Ultimate75% OFF

Mark Earl Hensley Insider Profile

4 Followers

Mark Earl Hensley, COO at Heron Therapeutics, holds 201.68K shares in Heron Therapeutics (Ticker: HRTX).

Mark Earl Hensley's Trading History

HRTX
Heron Therapeutics
Nov 10, 2026COOUninformative Buy6.48K$62.52K
HRTX
Insider Shares: 201.68K (0.11%)

Mark Earl Hensley has not reported any informative transactions for HRTX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Nov 10, 2026Uninformative Buy$6.48K22,361$0.29―
Nov 03, 2026Uninformative Buy$2.36K8,421$0.28―
Aug 10, 2026Uninformative Buy$11.18K22,362$0.50―
Aug 03, 2026Uninformative Buy$5.84K11,769$0.49―
May 07, 2026Uninformative Buy$163.75K125,000$1.31―

You May Also Like

Mark Earl Hensley insider profile FAQ

What stocks does Mark Earl Hensley hold?
Mark Earl Hensley holds: HRTX stocks.
What was Mark Earl Hensley’s latest transaction?
Mark Earl Hensley’s latest transaction was an Uninformative Buy of $6.48K.
What is Mark Earl Hensley's role in Heron Therapeutics?
Mark Earl Hensley's role in Heron Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.